Antiemetic therapy options for chemotherapy-induced nausea and vomiting in breast cancer patients
Vicky TC Chan, Winnie YeoDepartment of Clinical Oncology, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, ChinaAbstract: Chemotherapy-induced nausea and vomiting (CINV) continues to be one of the most distressing side effects of chemotherapy in breast cancer patients, which can...
Main Authors: | Chan VTC, Yeo W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-11-01
|
Series: | Breast Cancer : Targets and Therapy |
Online Access: | http://www.dovepress.com/antiemetic-therapy-options-for-chemotherapy-induced-nausea-and-vomitin-a8650 |
Similar Items
-
Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics
by: May MB, et al.
Published: (2016-05-01) -
A retrospective review of treatment patterns of antiemetic agents for chemotherapy-induced nausea and vomiting
by: Abdulrahman Alamri, et al.
Published: (2018-04-01) -
A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting
by: M. Clemons, et al.
Published: (2020-12-01) -
A randomized study of olanzapine-containing versus standard antiemetic regimens for the prevention of chemotherapy-induced nausea and vomiting in Chinese breast cancer patients
by: Winnie Yeo, et al.
Published: (2020-04-01) -
Chemotherapy-Induced Nausea and Vomiting (CINV) with GI Cancer Chemotherapy: Do We Need CINV Risk Score Over and Above Antiemetic Guidelines in Prescribing Antiemetic Regime?
by: Anita D’Souza, et al.
Published: (2020-10-01)